Mutations in BMP‐1/mTLD have been shown to cause osteogenesis imperfecta (OI), a disease primarily characterized by fragile bones that have a high susceptibility to fracture, along with neurological impairments 22, 23. This evidence concerns the gene BMP1 and osteogenesis imperfecta.